Sandbox:ap: Difference between revisions
Jump to navigation
Jump to search
Line 150: | Line 150: | ||
*Progressive external ophthalmoplegia | *Progressive external ophthalmoplegia | ||
*Retinitis pigmentosa | *Retinitis pigmentosa | ||
*Cardiomyopathy | *Cardiomyopathy | ||
*Heart block | *Heart block | ||
|- | |- | ||
Line 164: | Line 164: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | HADHA or HADHB gene mutation | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | HADHA or HADHB gene mutation | ||
| style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #F5F5F5;"| | ||
*Clinical features of mitochondrial trifunctional protein deficiency occurring during infancy include | *Clinical features of mitochondrial trifunctional protein deficiency occurring during infancy include: | ||
*Infants with mitochondrial trifunctional protein deficiency are also at | **Feeding difficulties | ||
*Clinical features of mitochondrial trifunctional protein deficiency occurring after infancy include | **Lethargy | ||
**Hypoglycemia | |||
**Hypotonia | |||
**Liver problems | |||
*Infants with mitochondrial trifunctional protein deficiency are also at increased risk for: | |||
**Serious heart problems | |||
**Breathing difficulties | |||
**Coma | |||
**Sudden death | |||
*Clinical features of mitochondrial trifunctional protein deficiency occurring after infancy include: | |||
**Hypotonia | |||
**Muscle pain | |||
**Breakdown of muscle tissue | |||
**Peripheral neuropathy | |||
|- | |- | ||
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (LCHAD deficiency)<ref name="pmid9403664">{{cite journal |vauthors=Tyni T, Rapola J, Palotie A, Pihko H |title=Hypoparathyroidism in a patient with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency caused by the G1528C mutation |journal=J. Pediatr. |volume=131 |issue=5 |pages=766–8 |year=1997 |pmid=9403664 |doi= |url=}}</ref> | | colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (LCHAD deficiency)<ref name="pmid9403664">{{cite journal |vauthors=Tyni T, Rapola J, Palotie A, Pihko H |title=Hypoparathyroidism in a patient with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency caused by the G1528C mutation |journal=J. Pediatr. |volume=131 |issue=5 |pages=766–8 |year=1997 |pmid=9403664 |doi= |url=}}</ref> | ||
Line 172: | Line 185: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |G1528C gene mutation | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |G1528C gene mutation | ||
| style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #F5F5F5;"| | ||
* Hypoglycemia | *Clinical features of LCHAD deficiency include: | ||
*Hepatopathy | **Hypoglycemia | ||
*Hypotonia | **Hepatopathy | ||
*Cardiomyopathy | **Hypotonia | ||
*Retinopathy | **Cardiomyopathy | ||
**Retinopathy | |||
|- | |- | ||
| rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Heavy metal storage disorders | | rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Heavy metal storage disorders | ||
Line 183: | Line 197: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |HFE gene mutation | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |HFE gene mutation | ||
| style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #F5F5F5;"| | ||
*Early symptoms of hereditary hemochromatosis are nonspecific and may include | *Early symptoms of hereditary hemochromatosis are nonspecific and may include: | ||
*Late stage clinical | **Fatigue | ||
**Joint pain | |||
**Abdominal pain | |||
**Decreased libido | |||
*Late stage clinical features may include: | |||
**Arthritis | |||
**Liver disease | |||
**Diabetes | |||
**Heart abnormalities | |||
**Skin discoloration. | |||
|- | |- | ||
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Wilson's disease<ref name="pmid6888480">{{cite journal |vauthors=Carpenter TO, Carnes DL, Anast CS |title=Hypoparathyroidism in Wilson's disease |journal=N. Engl. J. Med. |volume=309 |issue=15 |pages=873–7 |year=1983 |pmid=6888480 |doi=10.1056/NEJM198310133091501 |url=}}</ref><ref name="urlWilson disease - Genetics Home Reference">{{cite web |url=https://ghr.nlm.nih.gov/condition/wilson-disease#definition |title=Wilson disease - Genetics Home Reference |format= |work= |accessdate=}}</ref> | | colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Wilson's disease<ref name="pmid6888480">{{cite journal |vauthors=Carpenter TO, Carnes DL, Anast CS |title=Hypoparathyroidism in Wilson's disease |journal=N. Engl. J. Med. |volume=309 |issue=15 |pages=873–7 |year=1983 |pmid=6888480 |doi=10.1056/NEJM198310133091501 |url=}}</ref><ref name="urlWilson disease - Genetics Home Reference">{{cite web |url=https://ghr.nlm.nih.gov/condition/wilson-disease#definition |title=Wilson disease - Genetics Home Reference |format= |work= |accessdate=}}</ref> | ||
Line 190: | Line 213: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ATP7B gene mutation | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ATP7B gene mutation | ||
| style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #F5F5F5;"| | ||
* | *Clinical features of Wilson's disease include: | ||
* | **Initial feature | ||
*Other clinical features include | ***Children and young adults: Liver disease | ||
***Adults: nervous system disorders and psychiatric problems | |||
*Other clinical features include: | |||
**Clumsiness | |||
**Tremors | |||
**Difficulty walking | |||
**Speech problems | |||
**Impaired thinking ability | |||
**Depression | |||
**Anxiety | |||
**Mood swings. | |||
|} | |} | ||
<references /> | <references /> |
Revision as of 21:14, 29 September 2017
Hypercalcemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related to Parathyroid gland | Unrelated to parathyroid gland | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Primary hyperparathyroidism | Secondary hyperparathyroidism | Tertiary hyperparathyroidism | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Typical primary hyperparathyroidism | Familial hypocalciuric hypercalcemia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Malignancy | Medication induced | Nutritional | Granulomatous disease | Surgical | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Para-neoplastic syndrome: Parathyroid hormone related peptide | Metaplasia: Hypercalcemia due to bone destruction | Thiazide diuretics | Lithium | Milk alkali syndrome | Vitamin D toxicity | Sarcoidosis | Immobilization | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Differential diagnosis
Hypoparathyroidism | Inheritance | Gene mutation | Clinical features | |||
---|---|---|---|---|---|---|
Autoimmune[1] | Autoimmune polyglandular hypoparathyroidism | Autoimmune polyglandular endocrinopathy type 1 | Autosomal recessive | Mutation in AIRE gene |
| |
Isolated | Familial Isolated hypoparathyroidism | Autosomal dominant | PTH gene[2] |
| ||
GCM2 gene[3] |
| |||||
Autosomal recessive | PTH gene[4] |
| ||||
GCM2 gene[3][5] |
| |||||
X-linked | FHL1 gene (exon 4, c.C283T, p.R95W) on chromosome locus Xq26-q27.[6] |
| ||||
Autosomal dominant hypercalcemia[7] | Autosomal dominant hypocalcemia type 1 | Autosomal dominant | Calcium-sensing receptor gene mutation |
| ||
Autosomal dominant hypocalcemia type 2 | Autosomal dominant | G protein G11 (GNA11) mutation |
| |||
Congenital multisystem syndromes | DiGeorge syndrome[10] | Autosomal dominant | 22q11.2 deletion. |
| ||
CHARGE syndrome[11] | Autosomal dominant | CHD7 G744S missense mutation |
| |||
Kenny-Caffey syndrome type 1[12] | Autosomal recessive | Deletion of the TBCE gene |
| |||
Kenny-Caffey syndrome type 2[13] | Autosomal dominant | Mutation of “family with sequence similarity 111, member A″ (FAM111A) gene located on chromosome locus 11q12.1 |
| |||
Sanjad-Sakati syndrome[14] | Autosomal recessive | Mutation in TBCE gene. |
| |||
Barakat syndrome[15][16] | Autosomal recessive | Mutations in the GATA3 gene | ||||
Metabolic diseases | Mitochondiral polyneuropathies[17] | Kearns–Sayre syndrome | Mitochondrial inheritence | mtDNA deletion |
| |
Maternally inherited diabetes and deafness (MIDD) | Mitochondrial inheritence | MT‑TL1 |
| |||
Mitochondrial enzyme deficiencies | Mitochondrial trifunctional protein deficiency (MTP deficiency)[18][19] | Autosomal recessive | HADHA or HADHB gene mutation |
| ||
Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (LCHAD deficiency)[20] | Autosomal recessive | G1528C gene mutation |
| |||
Heavy metal storage disorders | Hemochromatosis[21][22] | Autosomal recessive | HFE gene mutation |
| ||
Wilson's disease[23][24] | Autosomal recessive | ATP7B gene mutation |
|
- ↑ Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J (1990). "Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients". N. Engl. J. Med. 322 (26): 1829–36. doi:10.1056/NEJM199006283222601. PMID 2348835.
- ↑ Arnold A, Horst SA, Gardella TJ, Baba H, Levine MA, Kronenberg HM (1990). "Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism". J. Clin. Invest. 86 (4): 1084–7. doi:10.1172/JCI114811. PMC 296835. PMID 2212001.
- ↑ 3.0 3.1 Canaff L, Zhou X, Mosesova I, Cole DE, Hendy GN (2009). "Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism". Hum. Mutat. 30 (1): 85–92. doi:10.1002/humu.20827. PMID 18712808.
- ↑ Sunthornthepvarakul T, Churesigaew S, Ngowngarmratana S (1999). "A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism". J. Clin. Endocrinol. Metab. 84 (10): 3792–6. doi:10.1210/jcem.84.10.6070. PMID 10523031.
- ↑ Ding C, Buckingham B, Levine MA (2001). "Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB". J. Clin. Invest. 108 (8): 1215–20. doi:10.1172/JCI13180. PMC 209530. PMID 11602629.
- ↑ Pillar N, Pleniceanu O, Fang M, Ziv L, Lahav E, Botchan S, Cheng L, Dekel B, Shomron N (2017). "A rare variant in the FHL1 gene associated with X-linked recessive hypoparathyroidism". Hum. Genet. 136 (7): 835–845. doi:10.1007/s00439-017-1804-9. PMC 5487855. PMID 28444561.
- ↑ Roszko KL, Bi RD, Mannstadt M (2016). "Autosomal Dominant Hypocalcemia (Hypoparathyroidism) Types 1 and 2". Front Physiol. 7: 458. doi:10.3389/fphys.2016.00458. PMC 5067375. PMID 27803672.
- ↑ Vezzoli G, Arcidiacono T, Paloschi V, Terranegra A, Biasion R, Weber G, Mora S, Syren ML, Coviello D, Cusi D, Bianchi G, Soldati L (2006). "Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome". J. Nephrol. 19 (4): 525–8. PMID 17048213.
- ↑ Choi KH, Shin CH, Yang SW, Cheong HI (2015). "Autosomal dominant hypocalcemia with Bartter syndrome due to a novel activating mutation of calcium sensing receptor, Y829C". Korean J Pediatr. 58 (4): 148–53. doi:10.3345/kjp.2015.58.4.148. PMC 4414630. PMID 25932037.
- ↑ Fomin AB, Pastorino AC, Kim CA, Pereira CA, Carneiro-Sampaio M, Abe-Jacob CM (2010). "DiGeorge Syndrome: a not so rare disease". Clinics (Sao Paulo). 65 (9): 865–9. PMC 2954737. PMID 21049214.
- ↑ Jain S, Kim HG, Lacbawan F, Meliciani I, Wenzel W, Kurth I, Sharma J, Schoeneman M, Ten S, Layman LC, Jacobson-Dickman E (2011). "Unique phenotype in a patient with CHARGE syndrome". Int J Pediatr Endocrinol. 2011: 11. doi:10.1186/1687-9856-2011-11. PMC 3216247. PMID 21995344.
- ↑ Metwalley KA, Farghaly HS (2012). "Kenny-Caffey syndrome type 1 in an Egyptian girl". Indian J Endocrinol Metab. 16 (5): 827–9. doi:10.4103/2230-8210.100645. PMC 3475915. PMID 23087875.
- ↑ Isojima T, Doi K, Mitsui J, Oda Y, Tokuhiro E, Yasoda A, Yorifuji T, Horikawa R, Yoshimura J, Ishiura H, Morishita S, Tsuji S, Kitanaka S (2014). "A recurrent de novo FAM111A mutation causes Kenny-Caffey syndrome type 2". J. Bone Miner. Res. 29 (4): 992–8. doi:10.1002/jbmr.2091. PMID 23996431.
- ↑ Rafique B, Al-Yaarubi S (2010). "Sanjad-Sakati Syndrome in Omani children". Oman Med J. 25 (3): 227–9. doi:10.5001/omj.2010.63. PMC 3191633. PMID 22043344.
- ↑ Muroya K, Hasegawa T, Ito Y, Nagai T, Isotani H, Iwata Y, Yamamoto K, Fujimoto S, Seishu S, Fukushima Y, Hasegawa Y, Ogata T (2001). "GATA3 abnormalities and the phenotypic spectrum of HDR syndrome". J. Med. Genet. 38 (6): 374–80. PMC 1734904. PMID 11389161.
- ↑ Van Esch H, Groenen P, Nesbit MA, Schuffenhauer S, Lichtner P, Vanderlinden G, Harding B, Beetz R, Bilous RW, Holdaway I, Shaw NJ, Fryns JP, Van de Ven W, Thakker RV, Devriendt K (2000). "GATA3 haplo-insufficiency causes human HDR syndrome". Nature. 406 (6794): 419–22. doi:10.1038/35019088. PMID 10935639.
- ↑ Chow J, Rahman J, Achermann JC, Dattani MT, Rahman S (2017). "Mitochondrial disease and endocrine dysfunction". Nat Rev Endocrinol. 13 (2): 92–104. doi:10.1038/nrendo.2016.151. PMID 27716753.
- ↑ Labarthe F, Benoist JF, Brivet M, Vianey-Saban C, Despert F, de Baulny HO (2006). "Partial hypoparathyroidism associated with mitochondrial trifunctional protein deficiency". Eur. J. Pediatr. 165 (6): 389–91. doi:10.1007/s00431-005-0052-5. PMID 16523289.
- ↑ "mitochondrial trifunctional protein deficiency - Genetics Home Reference".
- ↑ Tyni T, Rapola J, Palotie A, Pihko H (1997). "Hypoparathyroidism in a patient with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency caused by the G1528C mutation". J. Pediatr. 131 (5): 766–8. PMID 9403664.
- ↑ Jeong HK, An JH, Kim HS, Cho EA, Han MG, Moon JS, Kim HK, Kang HC (2014). "Hypoparathyroidism and subclinical hypothyroidism with secondary hemochromatosis". Endocrinol Metab (Seoul). 29 (1): 91–5. doi:10.3803/EnM.2014.29.1.91. PMC 3970271. PMID 24741460.
- ↑ "hereditary hemochromatosis - Genetics Home Reference".
- ↑ Carpenter TO, Carnes DL, Anast CS (1983). "Hypoparathyroidism in Wilson's disease". N. Engl. J. Med. 309 (15): 873–7. doi:10.1056/NEJM198310133091501. PMID 6888480.
- ↑ "Wilson disease - Genetics Home Reference".